| __timestamp | Alpine Immune Sciences, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 396000000 |
| Thursday, January 1, 2015 | 16054000 | 364000000 |
| Friday, January 1, 2016 | 23316000 | 376000000 |
| Sunday, January 1, 2017 | 10626000 | 382000000 |
| Monday, January 1, 2018 | 28970000 | 432000000 |
| Tuesday, January 1, 2019 | 35847000 | 457000000 |
| Wednesday, January 1, 2020 | 27185000 | 463000000 |
| Friday, January 1, 2021 | 58742000 | 508000000 |
| Saturday, January 1, 2022 | 70243000 | 539000000 |
| Sunday, January 1, 2023 | 80904000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Data in motion
In the ever-evolving landscape of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Zoetis Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting approaches to research and development (R&D) investments. From 2014 to 2023, Zoetis Inc. consistently outpaced Alpine Immune Sciences, Inc. in R&D spending, with Zoetis investing nearly 10 times more annually on average. In 2023, Zoetis allocated approximately 614% more to R&D than Alpine, underscoring its commitment to innovation. While Alpine's R&D expenses grew by over 600% from 2014 to 2023, Zoetis's strategic investments have positioned it as a leader in the industry. This data highlights the critical role of R&D in driving growth and maintaining competitive advantage in the pharmaceutical sector.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Zoetis Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.